Literature DB >> 15130787

Kinetics of oxygen binding to ferrous myeloperoxidase.

Walter Jantschko1, Paul Georg Furtmüller, Martina Zederbauer, Christa Jakopitsch, Christian Obinger.   

Abstract

Myeloperoxidase (MPO), which is involved in host defence and inflammation, is a unique peroxidase in having a globin-like standard reduction potential of the ferric/ferrous couple. Intravacuolar and exogenous MPO released from stimulated neutrophils has been shown to exist in the oxyferrous form, called compound III. To investigate the reactivity of ferrous MPO with molecular oxygen, a stopped-flow kinetic analysis was performed. In the absence of dioxygen, ferrous MPO decays to ferric MPO (0.04 s(-1) at pH 8 versus 1.4 s(-1) at pH 5). At pH 7.0 and 25 degrees C, compound III formation (i.e., binding of dioxygen to ferrous MPO) occurs with a rate constant of (1.1+/-0.1) x 10(4)M(-1)s(-1). The rate doubles at pH 5.0 and oxygen binding is reversible. At pH 7.0, the dissociation equilibrium constant of the oxyferrous form is (173+/-12)microM. The rate constant of dioxygen dissociation from compound III is much higher than conversion of compound III to ferric MPO (which is not affected by the oxygen concentration). This allows an efficient transition of compound III to redox intermediates which actually participate in the peroxidase or halogenation cycle of MPO.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130787     DOI: 10.1016/j.abb.2004.03.019

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Inhibition of Myeloperoxidase.

Authors:  Jala Soubhye; Paul G Furtmüller; Francois Dufrasne; Christian Obinger
Journal:  Handb Exp Pharmacol       Date:  2021

2.  A "sliding scale rule" for selectivity among NO, CO, and O₂ by heme protein sensors.

Authors:  Ah-Lim Tsai; Vladimir Berka; Emil Martin; John S Olson
Journal:  Biochemistry       Date:  2011-12-13       Impact factor: 3.162

3.  Interactions of hydrogen sulfide with myeloperoxidase.

Authors:  Zoltán Pálinkás; Paul G Furtmüller; Attila Nagy; Christa Jakopitsch; Katharina F Pirker; Marcin Magierowski; Katarzyna Jasnos; John L Wallace; Christian Obinger; Péter Nagy
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  CO binding and ligand discrimination in human myeloperoxidase.

Authors:  Emma J Murphy; Amandine Maréchal; Anthony W Segal; Peter R Rich
Journal:  Biochemistry       Date:  2010-03-16       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.